Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

More than 500,000 Britons are believed to be using weight loss drugs but a waning appetite is not all they report – there’s also a lack of desire to drink alcohol ...

Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Social media is alight with people who are sharing their experience of constant internal chatter about food. This so-called ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Expensive processed meals and fatty, chemical-laden treats are highly profitable, as a trip to any supermarket, where they ...

Dwindling supplies of Ozempic are fuelling an “exploding” black market for the drug across Australia, as the medical industry is forced to assess which patients need the popular medication the most.

Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...

The launch of Mounjaro demonstrates our ongoing support to this mission ... conditions such as diabetes and heart disease among others. Story continues below this ad The drug should not be prescribed ...

Iowa Attorney General Brenna Bird Friday, March 7 announced a multistate letter urging the Food and Drug Administration to take immediate action to stop the surge in dangerous, counterfeit weight ...